These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
36. Direct vascular effects of HMG-CoA reductase inhibitors. Laufs U; Liao JK Trends Cardiovasc Med; 2000 May; 10(4):143-8. PubMed ID: 11239793 [TBL] [Abstract][Full Text] [Related]
37. [Novel actions of HMG-CoA reductase inhibitors(statins)--vascular and cerebral protection through inhibition of small GTPase Rho]. Sawada N; Itoh H; Nakao K Nihon Rinsho; 2001 Dec; 59(12):2470-5. PubMed ID: 11766357 [TBL] [Abstract][Full Text] [Related]
38. Statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, function as inhibitors of cellular and molecular components involved in type I interferon production. Amuro H; Ito T; Miyamoto R; Sugimoto H; Torii Y; Son Y; Nakamichi N; Yamazaki C; Hoshino K; Kaisho T; Ozaki Y; Inaba M; Amakawa R; Fukuhara S Arthritis Rheum; 2010 Jul; 62(7):2073-85. PubMed ID: 20506142 [TBL] [Abstract][Full Text] [Related]
39. Pleiotropic Effects of Statins on the Cardiovascular System. Oesterle A; Laufs U; Liao JK Circ Res; 2017 Jan; 120(1):229-243. PubMed ID: 28057795 [TBL] [Abstract][Full Text] [Related]
40. Mevalonate Cascade and its Regulation in Cholesterol Metabolism in Different Tissues in Health and Disease. Hashemi M; Hoshyar R; Ande SR; Chen QM; Solomon C; Zuse A; Naderi M Curr Mol Pharmacol; 2017; 10(1):13-26. PubMed ID: 26758949 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]